Compare AKBA & HVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKBA | HVT |
|---|---|---|
| Founded | 2007 | 1885 |
| Country | United States | United States |
| Employees | N/A | 2392 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.0M | 336.7M |
| IPO Year | 2014 | N/A |
| Metric | AKBA | HVT |
|---|---|---|
| Price | $1.01 | $22.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.67 | N/A |
| AVG Volume (30 Days) | ★ 5.0M | 74.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.05% |
| EPS Growth | ★ 93.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.83 |
| Revenue Next Year | N/A | $8.70 |
| P/E Ratio | ★ N/A | $22.08 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $19.32 |
| 52 Week High | $4.08 | $27.67 |
| Indicator | AKBA | HVT |
|---|---|---|
| Relative Strength Index (RSI) | 34.96 | 55.80 |
| Support Level | N/A | $21.97 |
| Resistance Level | $1.56 | $23.58 |
| Average True Range (ATR) | 0.08 | 0.98 |
| MACD | -0.03 | 0.14 |
| Stochastic Oscillator | 19.55 | 91.67 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of revenue from its upholstery products and, secondarily, from bedroom furniture.